Rocket Pharmaceuticals stock gains on FDA gene therapy approval Rocket Pharmaceuticals stock gains on FDA gene therapy approval Rocket Pharmaceuticals (NASDAQ: RCKT) shares rose 6% Friday following the U.S.... Read More →